Vote FOR value creation
Vote FOR the directors who serve the best interests of ALL of NextGen Healthcare shareholders
Vote on the WHITE proxy card today
New leadership has transformed NextGen into a market leader with integrated and scalable platforms, a talented, diverse executive team and exceptionally engaged employees. With a strong foundation for sustainable growth, we have never been better positioned for significant shareholder value creation.
NextGen’s progress and the value of your shares are at risk. Sheldon Razin, the Company’s founder and 47-year tenured director, and his ally on the Board Lance Rosenzweig, have initiated a costly, disruptive and self-serving proxy contest. While they claim they are no longer seeking control of the NextGen Board, control was their intention from the start and their interests and motivations are very different from all other shareholders.
Our Achievements Over the Past Five Years Demonstrate Our SuccessLearn more about NextGen Healthcare
Increased highly valued subscription services annual revenue 91% to $148 million
Increased recurring revenue to 90% of total revenue from 80%
Made strategic acquisitions in analytics, connected health, integrated care and patient experience, which have materially broadened our portfolio and contributed to the Company’s accelerating revenue growth profile and its longer-term annual revenue growth goal
Became a top-rated Electronic Health Record and Practice Management vendor as measured by KLAS Research
Increased Net Promoter Score (NPS) by 53 points
Improved employee engagement by 33%, jumping well above benchmark and turning NextGen Healthcare into a destination for top talent
Don’t turn the Company over to Sheldon Razin so he can serve his own self-interests. Vote FOR all proposals on the WHITE proxy card.
Reincorporation of the Company in the State of DelawareLearn More
To approve provisions consistent with Delaware corporate law including approving a provision disallowing cumulative votingLearn More
Advisory approval of executive compensationLearn More
Ratification of auditorsLearn More
Amendment and restatement of 2015 Equity Incentive PlanLearn More
Election of each of the Company’s highly qualified director nomineesLearn More